NCT02208583 2014-08-05
Molecular Phenotype Changes and Personalized Treatment for CRPC
Tianjin Medical University Cancer Institute and Hospital
Phase NA Unknown
Clinical Trials
4 trialsNCT00313482 2012-05-11
PII Trial of Docetaxel/Prednisone w/Sargramostim for HRPC
Veeda Oncology
Phase 2 Terminated
NCT00525408 2012-03-12
HRPC
Cadila Pharnmaceuticals
Phase 2 Terminated
NCT00795171 2010-08-18
Biomarker Study for Sunitinib and Docetaxel in Prostate Cancer
Medical University of Vienna
Phase 2 Unknown